Effects of Long-term Use of Raloxifene, a Selective Estrogen Receptor Modulator, on Thyroid Function Test
暂无分享,去创建一个
[1] C. Christiansen,et al. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. , 2000, Archives of internal medicine.
[2] Yili Lu,et al. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women. , 2000, The Journal of clinical endocrinology and metabolism.
[3] S. Cummings,et al. The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial , 2000 .
[4] B. Walsh,et al. A 12‐Month Comparative Study of Raloxifene, Estrogen, and Placebo on the Postmenopausal Endometrium , 2000, Obstetrics and gynecology.
[5] R. Tracy,et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. , 2000, The Journal of clinical endocrinology and metabolism.
[6] J. Zidan,et al. Effect of Adjuvant Tamoxifen Therapy on Thyroid Function in Postmenopausal Women with Breast Cancer , 1999, Oncology.
[7] L. Kuller,et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. , 1998, JAMA.
[8] C. Christiansen,et al. EFFECTS OF RALOXIFENE ON BONE MINERAL DENSITY, SERUM CHOLESTEROL CONCENTRATIONS, AND UTERINE ENDOMETRIUM IN POSTMENOPAUSAL WOMEN , 1998 .
[9] C. Proukakis,et al. Thyroid function in postmenopausal women with breast cancer on tamoxifen. , 1998, European journal of gynaecological oncology.
[10] K. Tsai,et al. Effect of bone area on spine density in Chinese men and women in Taiwan. , 1997, Bone.
[11] D. Milne. Assessment of copper nutritional status. , 1994, Clinical chemistry.
[12] P. E. Johnson,et al. Assessment of copper status: effect of age and gender on reference ranges in healthy adults. , 1993, Clinical chemistry.
[13] A. Noma,et al. Sensitive, direct procedures for simultaneous determinations of iron and copper in serum, with use of 2-(5-nitro-2-pyridylazo)-5-(N-propyl-N-sulfopropylamino)phenol (nitro-PAPS) as ligand. , 1992, Clinical Chemistry.
[14] S. Reznikov,et al. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. , 1991, The Journal of clinical endocrinology and metabolism.
[15] T. Makino. A sensitive, direct colorimetric assay of serum copper using 5-Br-PSAA. , 1989, Clinica chimica acta; international journal of clinical chemistry.
[16] K. Ain,et al. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. , 1987, The Journal of clinical endocrinology and metabolism.
[17] T. R. Custer,et al. Free Thyroxine and Free Thyroxine Index In Women Taking Oral Contraceptives , 1981, Clinical Nuclear Medicine.
[18] T. Risby,et al. Elemental Trace Analysis of Biological Materials , 1979 .
[19] D. Glinoer,et al. Use of direct thyroxine-binding globulin measurement in the evaluation of thyroid function , 1978, Journal of endocrinological investigation.
[20] J. Oppenheimer. Role of plasma proteins in the binding, distribution and metabolism of the thyroid hormones. , 1968, The New England journal of medicine.
[21] B. Zak,et al. Determination of serum copper and iron in a single small sample. , 1958, American journal of clinical pathology.
[22] N. Ressler,et al. Simultaneous Microdetermination of Copper and Iron Using Mixed Phenanthrolines , 1956 .
[23] R. H. Bray,et al. Two specific methods of determining copper in soil and in plant material. , 1953 .
[24] S. Wiberley,et al. COLORIMETRIC ESTIMATION OF VARIOUS METAL DERIVATIVES OF SODIUM DIETHYLDITHIOCARBAMATE , 1951 .
[25] J. C. Robinson,et al. A simple method for determining serum copper. , 1949, The Journal of biological chemistry.
[26] Laurell Cb,et al. Investigations in serum copper. , 1948 .